Active versus sham DLPFC-NAc rTMS for depressed adolescents with anhedonia using resting-state functional magnetic resonance imaging (fMRI): a study protocol for a randomized placebo-controlled trial.

Authors:
Lv R; Cai M; Tang N; Shi Y; Zhang Y and 4 more

Journal:
Trials

Publication Year: 2024

DOI:
10.1186/s13063-023-07814-y

PMCID:
PMC10787505

PMID:
38218932

Journal Information

Full Title: Trials

Abbreviation: Trials

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study protocol was approved by the Ethics Committee of Xijing Hospital in Shaanxi Province, China, and was registered at ClinicalTrials.gov (URL: the Safety and Effectiveness of Precise rTMS Based on Neuroimaging in the Treatment of Adolescent Depression With Anhedoniadepression With Anhedonia—Full Text View—ClinicalTrials.gov reference number: NCT05544071). Participants will be required to provide informed consent forms. Consent for publicationThis manuscript and the provided sample of the informed consent form do not contain the personal data of the patients. Except for current information, participant information materials and informed consent forms will be available from the corresponding author upon request. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This study received financial support from the National Natural Science Foundation of China (grant number 81974215). The funder has no role in collecting, analyzing, and interpreting data or writing manuscripts."

Evidence found in paper:

"Trial registration ClinicalTrials.gov NCT05544071. Registered on 16 September 2022."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025